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The transcriptional activator MyoD serves as a master controller of myogenesis. Often in partnership with Mef2
(myocyte enhancer factor 2), MyoD binds to the promoters of hundreds of muscle genes in proliferating myoblasts
yet activates these targets only upon receiving cues that launch differentiation. What regulates this off/on switch
of MyoD function has been incompletely understood, although it is known to reflect the action of chromatin
modifiers. Here, we identify KAP1 (KRAB [Kr€uppel-like associated box]-associated protein 1)/TRIM28 (tripartite
motif protein 28) as a key regulator of MyoD function. In myoblasts, KAP1 is present with MyoD and Mef2 at
many muscle genes, where it acts as a scaffold to recruit not only coactivators such as p300 and LSD1 but also
corepressors such as G9a and HDAC1 (histone deacetylase 1), with promoter silencing as the net outcome. Upon
differentiation, MSK1-mediated phosphorylation of KAP1 releases the corepressors from the scaffold, unleashing
transcriptional activation by MyoD/Mef2 and their positive cofactors. Thus, our results reveal KAP1 as a
previously unappreciated interpreter of cell signaling, which modulates the ability of MyoD to drive myogenesis.
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The discovery that fibroblasts could be induced to un-
dergo myogenic differentiation by the forced expression
of the DNA-binding basic helix–loop–helix (bHLH)MyoD
protein was the first experimental evidence of genetically
programmed transdifferentiation (Davis et al. 1987).MyoD
was subsequently demonstrated to act as a master regula-
tor of skeletal myogenesis driving myoblasts into a gene
expression cascade that leads to their differentiation into
multinucleatedmyotubes (Tapscott 2005; Aziz et al. 2010).
It also became apparent that MyoD orchestrates this
program by cooperating with a number of other modula-
tors of gene expression, be they transcription factors or
chromatin modifiers. How these multiple interactions are
regulated and how MyoD-dependent gene targets are
defined are still incompletely understood. In muscle pre-
cursor cells, MyoD indeed binds as a heterodimer with
ubiquitously expressed E proteins to thousands of genomic
sites containing a so-called E-box sequence (CAGSTG)
(Cao et al. 2010; Soleimani et al. 2012). However, only
a fraction of the genes situated nearby are activated during
myotube differentiation (Cao et al. 2010). Interestingly,
this subset of MyoD-recruiting genes is also enriched in
Mef2 (myocyte enhancer factor 2) (Cao et al. 2010), and,
more generally, MyoD- and Mef2-binding elements are
overrepresented in cis-regulatory modules (CRMs) active
during muscle differentiation (Kwon et al. 2011). MyoD
and Mef2 also cooperate during muscle regeneration,
where MyoD levels first increase in satellite cells, contrib-
uting to the expansion of these progenitors (Zhang et al.
2010; Singh and Dilworth 2013) before initiating with
Mef2 the myogenic gene expression program that leads
to cell cycle exit and formation of functional multinucle-
ated myotubes (Penn et al. 2004; Liu et al. 2012; Singh and
Dilworth 2013). This is consistent with the recruitment by
the two factors of a combination of coregulatorymolecules
necessary for activating the muscle gene expression pro-
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gram (Molkentin et al. 1995; Rampalli et al. 2007). Sup-
porting this model, MyoD interacts directly with compo-
nents of the basal transcriptional machinery (Heller and
Bengal 1998; Deato et al. 2008) and with the BAF60c
subunit of the SWI/SNF complex (Forcales et al. 2012),
whileMef2D recruits the Ash2L/MLL2–methyltransferase
complex, which mediates trimethylation of histone H3
Lys4 (H3K4me3). A transcriptionally favorable epigenetic
state is thus created, a prerequisite for high-level expres-
sion of muscle-specific genes (Rampalli et al. 2007).
However, in proliferating myoblasts, both MyoD and
Mef2 are already bound to the CRMs of muscle differen-
tiation genes yet are not expressed (Cao et al. 2010). Some
of this paradoxmay stem from themethylation and hence
inactivation of MyoD (Ling et al. 2012) and Mef2 (Choi
et al. 2014) by the histone methyltransferase G9a in these
cells.MyoD andMef2 are indeed able to interactwith either
activators, such as the histone acetyltransferase p300
(Sartorelli et al. 1997) and the histone demethylase LSD1
(Choi et al. 2010), or repressors, such as G9a (Ling et al.
2012; Choi et al. 2014). Nevertheless, how the differential
recruitment of these cofactors is regulated and hence how
MyoD and Mef2D switch from repressors of muscle differ-
entiation genes in proliferating myoblasts to activators of
their expression in myotubes remain enigmatic.
Here, we identify KAP1 (KRAB [Kr€uppel-like associated
box]-associated protein 1) as a crucial component of these
events. KAP1, also known as TRIM28 (tripartite motif
protein 28) or TIF1b (transcription intermediary factor
1b), is the universal cofactor of hundreds of KRAB domain-
containing zinc finger proteins (KRAB-ZFPs), which are
sequence-specific transcriptional repressors responsible for
the early embryonic silencing of endogenous retroelements
(EREs) (Wolf and Goff 2007; Rowe et al. 2010; Castro-Diaz
et al. 2014; Turelli et al. 2014). Upon KRAB-ZFP-mediated
tethering to DNA, KAP1 recruits the H3K9 methyltrans-
ferase SETDB1, the histone deacetylase (HDAC)-contain-
ing NuRD complex, heterochromatin protein 1 (HP1), and
DNA methyltransferases, which results in heterochroma-
tin formation and silencing of the targeted loci (Friedman
et al. 1996; Schultz et al. 2001, 2002; Ivanov et al. 2007;
Quenneville et al. 2012; Rowe et al. 2013a). KAP1 is also
involved in DNA repair, where its phosphorylation at
either one of two serine residues (473 and 824) transiently
alters its heterochromatin-inducing activity (White et al.
2006, 2012; Iyengar and Farnham 2011). In the present
study, we unveil KAP1 as an essential cofactor of MyoD-
induced gene expression and MSK1-mediated KAP1 phos-
phorylation as a key regulator of this process.
Results
MyoD and Mef2D interact with KAP1 in myoblasts
and myotubes
In proliferating myoblasts, the binding of MyoD to the
promoter of muscle genes is not sufficient to induce their
expression (Cao et al. 2010). To identify factors thatmight
repress MyoD function in this setting, we performed
proteomic analysis of MyoD-interacting proteins (Fig. 1A;
Supplemental Fig. S1A). Mass spectrometry confirmed
many known MyoD-interacting proteins (Supplemental
Table S1), including its E-protein dimerization partners
(TCF3, TCF4, and TCF12) (Lassar et al. 1991) and the
transcriptional coactivator p300 (Sartorelli et al. 1997).
Among several novel MyoD interactors detected through
this analysis, our attention was attracted to KAP1 because
of its known ability to recruit chromatin modifiers.
Reciprocal coimmunoprecipitation experiments con-
firmed that MyoD and KAP1 form a complex in pro-
liferating C2 myoblasts and, interestingly, also detected
an association between these two proteins in differenti-
ating myotubes (Fig. 1B). In vitro pull-down assays using
purified MyoD and recombinant KAP1 demonstrated
that their interaction is direct and requires the RBCC
(RING B-box coiled-coil) domain of KAP1 (Fig. 1C), while
immunoprecipitation of wild-type or deleted forms of
HA-tagged MyoD indicated that it is dependent on the
bHLH domain of this protein (Supplemental Fig. S1B).
The ability to interact with KAP1 is a characteristic that
is shared with the related muscle bHLH transcription
factor Myf5 (Supplemental Fig. S2A). In addition, we
found that KAP1 could also be immunoprecipitated with
Mef2D in both myoblasts and myotubes (Fig. 1B), and in
vitro pull-down experiments demonstrated that interac-
tion between these two factors is direct and alsomediated
through the RBCC domain of KAP1 (Fig. 1C).
KAP1 is necessary for myoblast differentiation
To investigate the functional significance of the associa-
tion of MyoD and Mef2D with KAP1, we depleted this
factor in myoblasts by RNAi using lentiviral vectors
expressing shRNAs against Kap1 with (shRescue) or
without (shKap1) an shRNA-resistant codon-optimized
Kap1 RNA for control complementation (Fig. 2A,B).
KAP1 depletion did not result in detectable changes in
the cell cycle progression of myoblasts (Supplemental Fig.
S2B; data not shown) but blocked their differentiation
into multinucleated myotubes (Fig. 2C). This correlated
with decreased expression of the muscle-specific genes
MyoD, Myogenin (Myog), myosin heavy chain (MHC),
muscle creatine kinase (CKm), Hairy-Enhancer of Split
homolog 6 (Hes6), and Desmin (Fig. 2D,E). Importantly,
this differentiation block was directly attributable to the
absence of KAP1, since the myogenic program could be
restored by adding back this protein (Fig. 2C–E). Thus,
KAP1 is required for the expression of key MyoD and
Mef2 target genes such as Myog, a factor that mediates
the cell cycle exit and terminal differentiation of myo-
blasts (Liu et al. 2012; Singh and Dilworth 2013).
KAP1 coregulates muscle gene expression
To explore fully the muscle gene expression program
regulated by KAP1, we performed high-throughput se-
quencing of RNA (RNA-seq) isolated from myoblasts and
differentiating myotubes in which KAP1 had been de-
pleted by lentivector-mediated RNAi. Taking twofold as
a cutoff, KAP1 knockdown altered the expression of 220
genes in proliferating myoblasts and 1363 genes in their
Singh et al.
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differentiated counterparts, of which only a minority (71
and 418, respectively) was up-regulated (Supplemental
Table S2). Gene set enrichment analysis (Subramanian
et al. 2005) of the corresponding subset of deregulated
genes was consistent with a role for KAP1 in regulating
the activation of genes involved in muscle function
(Supplemental Table S2).
To identify the direct targets of KAP1 regulation among
these genes, we proceeded to chromatin immunoprecip-
itation (ChIP) coupled to high-throughput sequencing
(ChIP-seq). This analysis identified 19,549 and 6456
KAP1-enriched loci on the genome of proliferating myo-
blasts and differentiating myotubes, respectively. How-
ever, these KAP1 peaks were only rarely associated with
the H3K9me3 mark (Supplemental Fig. S3A) typically
found at KAP1-induced heterochromatin regions (Schultz
et al. 2002). This is consistent with previous observations
indicating that H3K9me3 does not significantly contrib-
ute to the regulation of muscle gene expression during
myogenesis (Pauler et al. 2009; Asp et al. 2011). It further
suggested that KAP1 might act in a nonprototypic fashion
to regulate myogenesis. To probe this issue and ask more
specifically how MyoD and KAP1 might coregulate mus-
cle gene expression, we overlapped our KAP1 ChIP-seq
data with those previously obtained for MyoD (Cao et al.
2010). This revealed that the two proteins colocalize at
1314 and 568 genomic loci in proliferating and differenti-
ating myoblasts, respectively (Fig. 3A), which represent
;10% of KAP1 genomic binding sites in each condition.
Furthermore, a census of loci enriched for both KAP1 and
MyoD in myotubes revealed that about a third of them
already carried these two proteins in myoblasts (Fig. 3B).
MyoD characteristically binds to tissue-specific en-
hancers in muscle, whether at the myoblast or myotube
stage (Blum et al. 2012). We thus asked whether KAP1
also associated with these elements. We examined sites
of overlap between KAP1 and MyoD within 50 kb from
a transcription start site (TSS) as a cutoff, as this has been
reported as themedian distance between an enhancer and
its target promoter (Kim et al. 2010; Rada-Iglesias et al.
2011; Blum et al. 2012). We found that the majority of loci
cobound by MyoD and KAP1 was within this interval in
bothmyoblasts andmyotubes (Fig. 3B) and that a significant
proportion of these was at the gene promoters themselves,
Figure 1. KAP1 interacts with MyoD and
Mef2D in muscle cells. (A) Nuclear extracts
(NEs) prepared from C2 myoblasts express-
ing a doxycycline-inducible Flag-MyoD were
subjected to immunoprecipitation using an
anti-Flag antibody. Coimmunoprecipitated
proteins were resolved on SDS-PAGE, visual-
ized by silver staining, and identified by mass
spectrometry. The interaction network was
prepared using Cytoscape version 3.1.0 (see
also Supplemental Fig. S1A). (B) Immunopre-
cipitations were performed using NEs pre-
pared with either proliferating myoblasts or
differentiating myotubes using antibodies
against MyoD, Mef2D, or KAP1. Immunopre-
cipitated proteins were analyzed by Western
blot using the indicated antibodies. (C) Exog-
enous Flag-KAP1 (full-length or its various
domain deletion mutants) was purified from
SF9 cell extracts using anti-Flag magnetic
beads. Purified KAP1 proteins were left bound
to the Flag beads and further incubated with
purified MyoD and Mef2D for 3 h at room
temperature. After extensive washing, Flag-
KAP1-associated proteins were eluted and
analyzed by Western blot using the indicated
antibodies (see also Supplemental Fig. S1B).
KAP1 phosphorylation regulates myogenesis
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defined as a region 62 kb from the TSS (Supplemental Fig.
S5A). Consistent with MyoD and KAP1 associating at
transcriptional enhancers, regions cobound by MyoD and
KAP1 were significantly enriched for the enhancer-associ-
ated histone modifications H3K27ac and H3K4me1 but
not the heterochromatin mark H3K9me3, which marks
KAP1-induced heterochromatin (Supplemental Fig. S4).
Taken together, these results strongly suggest that KAP1
and MyoD cooperate to control muscle gene expression
both before and after myoblast differentiation.
To define further the importance of KAP1 in the regula-
tion of muscle genes, we also examined the binding overlap
between KAP1 and MyoD with published Mef2Da2
ChIP-seq data of differentiating myotubes (Sebastian
et al. 2013). This revealed that 134 of the 146 TSS-close
(MyoD+KAP1)-bearing sites were also adorned with
Mef2Da2 (Supplemental Fig. S5B). Among genes poten-
tially subjected to KAP1/MyoD/Mef2Da2-mediated reg-
ulation in both myoblasts and myotubes, we identified
the muscle-specific long noncoding RNA (lncRNA) lnc-
MD1 (Fig. 3C; Cesana et al. 2011; Legnini et al. 2014),
confirming the ChIP-seq data by quantitative PCR
(qPCR) on independent chromatin immunoprecipitates
(Fig. 3D). Focusing our analysis on this lncRNA andMyog
as two key regulators ofmyogenic differentiation targeted
by the MyoD/Mef2D/KAP1 complex, we could deter-
mine that the presence of KAP1 at the promoters of these
genes was MyoD-dependent, since it was completely
abrogated by MyoD depletion in both proliferating and
differentiating myoblasts (Fig. 3D). In addition, lnc-MD1
levels were decreased upon Kap1 knockdown (Fig. 3E), as
previously observed for Myog (Fig. 2D). Correspondingly,
KAP1 depletion reduced the levels of lnc-MD1 target gene
products, including miR-206, during myogenic differen-
tiation (Fig. 3E,F; Supplemental Fig. S6A).
A KAP1 phosphorylation switch controls muscle
differentiation
These results established KAP1 as a coactivator ofMyoD/
Mef2D-dependent gene expression, reminiscent of its
previously reported stimulation of Nur77 transcriptional
activating potential (Rambaud et al. 2009). However, the
association of KAP1 with MyoD and Mef2D in both
Figure 2. KAP1 is essential for myoblast differen-
tiation. (A,B) KAP1 knockdown and recomplemen-
tation efficiency were assessed by RT-qPCR (A) and
Western blot (B) in C2 myoblasts transduced with
lentiviral vectors expressing either a control shRNA
(shCtrl), a Kap1 targeting shRNA (shKAP1), or
a Kap1 targeting shRNA together with a shRNA-
resistant Kap1 allele (shRescue). In (A), values were
calculated as the mean relative expression after
normalization to three housekeeping genes 6
SEM. n = 3; (*) P < 0.01; (nd) not determined. (C)
Representative immunofluorescence images and
myogenic fusion efficiency indicating the percent-
age of nuclei present within multinucleated cells,
based on counting 10 unbiased fields per time point.
Values were calculated as mean 6 SEM. (**) P <
0.01. Bar, 200 mm. (D) RNA was isolated from
infected C2 myoblasts that had been induced to
differentiate. RT-qPCR analysis was performed us-
ing primers directed at specific genes, as indicated
(see Supplemental Table S3 for primer sequences).
Values were calculated as the mean relative expres-
sion after normalization to three housekeeping
genes 6 SEM. n = 3; (*) P < 0.05; (**) P < 0.01
shCtrl versus shKAP1. (E) Western blot analysis for
MHC expression in shCtrl, shKAP1, and shRescue
C2C12 myoblasts at different time points of differ-
entiation. b-Actin was used as an internal loading
control. One representative experiment out of three
is presented.
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myoblasts, where their target genes are repressed, and
myotubes, where they are induced, suggested that KAP1
action must be regulated. KAP1 was previously demon-
strated to undergo post-translational modifications and
have its corepressor activity reduced notably by phos-
phorylation on Ser473 (Chang et al. 2008; King 2013).
Remarkably, while KAP1 protein levels remained rela-
tively constant when myoblasts were induced to differ-
entiate into myocytes, its S
473pKAP1 isoform became
detectable during this process (Fig. 4A). The transient
Figure 3. KAP1, MyoD, and Mef2D genomic corecruitment controls muscle genes. (A) Venn diagram showing the genome-wide overlap
between the KAP1 and MyoD peaks identified by ChIP-seq in proliferating (MB) or differentiating (MT) C2 myoblasts. (B) Venn diagram
illustrating the degree to which KAP1 and MyoD overlapping peaks are shared between myoblasts and myotubes either genome-wide or
when limiting the analysis to gene regulatory regions (650 kb TSS). (C) Sequencing reads were mapped across the lnc-MD1 locus for ChIP
experiments performed using KAP1 (black), MyoD (red), and Mef2Da2 (blue) antibodies and for RNA-seq experiments performed in shCtrl
and shKAP1myoblasts (MB) or myotubes (MT) (see also Supplemental Fig. S5B). (D) Knockdown ofMyoD (shMyoD) or control (shCtrl) was
induced in C2 myoblasts before subjecting myoblasts (MB) or differentiating myotubes (MT) to ChIP-qPCR with KAP1-specific antibodies.
The well-characterized KAP1 target ZFP180 was used as a positive control, while GAPDH was used as a negative control. Values are
represented as mean 6 SEM and were calculated as relative enrichment over the Tubb2 promoter as a negative control, where P < 0.05 (*).
(n.s.) Not significant. (E) RT-qPCR analysis for lnc-MD1 and miR-206 at various time points of differentiation in shCtrl, shKAP1, and
shRescue myoblasts. Values were calculated as relative expression6 SEM and normalized over three housekeeping genes for lnc-MD1 and
three housekeeping snoRNAs formiR-206 expression. n = 3; (*) P < 0.05 shCtrl versus shKAP1. (F) Western blot for the lnc-MD1-regulated
transcriptional coactivator MEF2C at different time points of differentiation in shCtrl, shKap1, and shRescue myoblasts. b-Actin was used
as an internal loading control. One representative experiment out of three is shown (see also Supplemental Fig. S6A).
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nature of the KAP1 phosphorylation event and its occur-
rence at a limited number of genomic loci exclusively in
differentiating myoblasts made it difficult to document
strong phosphorylation of KAP1 in extracts prepared
from regenerating adult mouse muscle (Supplemental
Fig. S5C–E). However, we observed a dramatic augmen-
tation of S
473pKAP1 levels upon differentiation of primary
mouse myoblasts isolated from the tibialis anterior
muscle (Fig. 4B). We next set out to identify the kinase
responsible for this process. Previous work suggested that
S
473KAP1 phosphorylation is mediated by the MK2 ki-
nase in endothelial cells (King 2013). However, treatment
of myoblasts with the MK2 inhibitor PF3644022 surpris-
ingly led to increased levels of S
473pKAP1 (Fig. 4C) and
higher efficiency of myotube formation (Supplemental
Fig. S7A). Instead, pharmacological inhibitors of two
other kinases previously found to be active in muscle
cells—SB20350 (active on p38MAPK) and H89 (targeting
MSK1)—prevented the accumulation of S
473pKAP1 (Fig.
4C). As the S473 residue does not lie within a consensus
p38 MAPK site, we probed further the potential role of
MSK1 in S
473KAP1 phosphorylation. Using purified
GST-KAP1 protein and a constitutively active recombi-
nant MSK1 protein, we found that the wild-type KAP1
protein, but not an S473 mutant (S
473
AKAP1), was effi-
ciently phosphorylated by MSK1 in vitro (Fig. 4D).
Furthermore, shRNA-mediated knockdown of MSK1
was sufficient to reduce PF3644022-induced S
473KAP1
phosphorylation in proliferating myoblasts (Fig. 4E).
Finally, we could document the recruitment of MSK1
at both the lnc-MD1 and Myog promoters in differenti-
ating myotubes (Fig. 4F).
Consistent with an important role for S
473KAP1 phos-
phorylation in MyoD-dependent myoblast differentia-
tion, KAP1-depleted myoblasts complemented with the
nonphosphorylatable S
473
AKAP1 mutant could neither
morph into myotubes (Fig. 5A–C) nor efficiently induce
the expression of MyoD/KAP1 target genes (Fig. 5D).
KAP1 phosphorylation triggers the release of repressor
chromatin modifiers
Having established KAP1 S473 phosphorylation as a mo-
lecular switch promoting myoblast differentiation, we
sought to understand the mechanism of this phenome-
non. KAP1 typically acts as a scaffold for the recruitment
of chromatin-modifying enzymes and other transcription
modulators (Friedman et al. 1996; Underhill et al. 2000;
Schultz et al. 2001, 2002; Ivanov et al. 2007; Quenneville
et al. 2012). Transcriptional repressors known to interact
with both KAP1 and MyoD include HDAC1 and the
protein methyltransferase G9a (Underhill et al. 2000;
Schultz et al. 2001; Mal and Harter 2003; Fritsch et al.
2010; Ling et al. 2012). Accordingly, we could coimmu-
noprecipitate KAP1 with HDAC1 and G9a and its di-
merization partner, GLP, in proliferating myoblasts (Fig.
6A,B). We also detected in these cells an interaction of
KAP1 with the histone demethylase LSD1 and the
histone acetyltransferases p300; that is, two enzymes
with activities antagonistic to those of G9a/GLP and
HDAC1, respectively (Fig. 6A). We next examined how
KAP1 S473 phosphorylation influences these interactions.
For this, we treated proliferating myoblasts with
PF3644022, since we had found this MK2 inhibitor to
Figure 4. MSK1 phosphorylates KAP1 during muscle
differentiation. (A,B) Cell extracts were prepared from
C2 myoblasts (A) or primary mouse myoblasts (B) at
various stages of differentiation. Western blot was
performed using antibodies as indicated. (C) Differenti-
ating C2 myoblasts were treated with the pharmaco-
logical inhibitors SB203580 (p38 MAPK), H89 (MSK1),
or PF3644022 (MK2) for 2 h prior to harvesting. Western
blot analysis was performed for both KAP1 and
S
473pKAP1 (see also Supplemental Fig. S7A). (D) Phos-
phorylation of KAP1 by MSK1 was evaluated in vitro by
incubating active Flag-MSK1 (CA-MSK1) with purified
GST-KAP1 wild-type or S
473
A mutant proteins in the
presence of ATP as outlined in the Supplemental
Material. Kinase reactions were analyzed by Western
blot using the indicated antibodies. An asterisk in-
dicates a heavy chain of IgG. (E) C2 myoblasts were
infected with lentivirus expressing either shMSK1 or
shCtrl and incubated with the MK2 inhibitor
PF3644022 for 2 h to induce KAP1 phosphorylation.
Cell extracts were analyzed by Western blot using the
indicated antibodies. (F) Chromatin was prepared from
either proliferating myoblasts or differentiating myo-
tubes and was subjected to ChIP-qPCR analysis using
antibodies directed against MSK1. Immunoprecipitated
DNA was quantitated relative to the input chromatin
and is expressed as the mean 6 SEM. (**) P < 0.01; (n.s.)
not significant.
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induce KAP1 phosphorylation (Fig. 4C). This resulted in
abrogating KAP1 association with G9a and HDAC1 but
not with LSD1 (Fig. 6C). Consistent with this observa-
tion, we found that KAP1 interacts strongly with LSD1
and p300 in differentiating myotubes, where it exhibits
significant rates of S473 phosphorylation (Fig. 6D–F). To
strengthen the link between KAP1’s phosphorylation
status and its association with these chromatin modi-
fiers, we examined the binding partners of KAP1 point
mutants that were either phosphomimetic (S
473
DKAP1) or
phosphorylation-resistant (S
473
AKAP1) at position 473.
We found that both G9a and HDAC1 interacted with
S
473
AKAP1 but not with S
473
DKAP1 (Fig. 6G). In contrast,
the transcriptional coactivators (LSD1 and p300) and
transcription factors (MyoD and MEF2D) maintained
their association with both mutant forms of the Kap1
(Fig. 6G; Supplemental Fig. S7B,C).
We then performed ChIP-qPCR analyses in cells de-
pleted for wild-type KAP1 and complemented with
S
473
AKAP1 (Fig. 6H). The results revealed that, in the
presence of this phosphorylation-resistant KAP1 mutant,
both HDAC1 and G9a remained associated with the
previously mapped MyoD/Mef2D-bound Myog and
lnc-MD1 loci when myoblasts were placed in differen-
tiation medium, consistent with a model in which it is
KAP1 phosphorylation that normally triggers the
release of these transcriptional corepressors from these
sites.
In growing myoblasts, both MyoD and Mef2D are
functionally inactivated by G9a-mediated methylation
(Ling et al. 2012; Choi et al. 2014). Upon differentiation,
these factors are demethylated, which allows them to
activate muscle gene expression. For Mef2D, LSD1 was
identified as the demethylase responsible for removing
methyl residues deposited by G9a at Lys267 (Choi et al.
2014). Therefore, we examined the influence of KAP1 on
this process (Fig. 7A). By comparing cells with different
levels of KAP1 knockdown, we first observed that levels
of methylated Mef2D (K
267meMef2D) were proportional
to residual KAP1 levels. We then measured the recruit-
ment of coregulatory molecules to muscle genes in pro-
liferating myoblasts exposed or not exposed to the KAP1
S473 phosphorylation-inducing compound PF3644022
(Fig. 7B). We found that PF3644022 treatment was suffi-
cient to induce expression of both theMyog and lnc-MD1
genes in these cells (Fig. 7C). This transcriptional activa-
tion was not the result of increased recruitment of KAP1,
MyoD, Mef2D, or LSD1 at either locus. Instead, it
correlated with a drastic decrease in HDAC1 enrichment,
mirrored by a significant increase in the presence of p300
and acetylated histone H3 (Fig. 7D).
Finally, we could determine that the knockdown of
KAP1 led to significant decreases in the recruitment of
both p300 and LSD1 at the lnc-MD1 andMyog promoters
in differentiating myoblasts, with a commensurate drop
in levels of H3K27ac, a mark deposited by p300, but no
change in H3K4me3 (Fig. 7E; Supplemental Fig. S6B,C).
Taken together, these results support a model in which
KAP1 serves as a scaffold for the docking at MyoD/
Mef2D targeted muscle gene CRMs of a set of chromatin
Figure 5. KAP1 S473 phosphorylation is re-
quired for myoblast differentiation. (A–D) C2
myoblasts were infected with lentivirus
expressing shCtrl, shKAP1, or KAP1 targeted
shRNA together with an shRNA-resistant
allele of either the wild type or a nonphos-
phorylatable S473 KAP1 mutant (S
473
AKAP1).
(A) Representative immunofluorescence im-
ages. (B) Myogenic fusion efficiency showing
the percentage of nuclei present within mul-
tinucleated cells taken from 10 unbiased
fields per time point. Values were calculated
as mean 6 SEM. (**) P < 0.0001. Bar, 200 mm.
(C) The efficiency of KAP1 knockdown and
rescue with shRNA-resistant cDNAs was
evaluated by Western blot analysis. (D) RNA
was isolated from infected C2 myoblasts that
had been induced to differentiate, and RT-
qPCR analysis was performed using primers
directed at specific genes as indicated. Values
were calculated as the mean relative expres-
sion after normalization to three housekeep-
ing genes6 SEM. n = 3; (*) P < 0.01 S
473
AKAP1
versus shCtrl.
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modifiers, the composition of which is regulated by KAP1
phosphorylation, which acts as a molecular switch acti-
vating these genes when myoblasts are induced to differ-
entiate into myotubes.
Discussion
We set out to understand how MyoD can bind the CRMs
of hundreds of muscle genes in proliferating myoblasts
and yet activate its targets only once these cells are
induced to differentiate into myotubes. Here we conclu-
sively demonstrate that the scaffold protein KAP1 acts as
a key determinant of MyoD function during muscle
differentiation. Indeed, KAP1 associates with the DNA-
bound MyoD and Mef2D within the regulatory region of
muscle genes in proliferating myoblasts, where it acts as
a scaffolding for the recruitment of a combination of
activating (p300 and LSD1) and repressive (G9a and
HDAC1) chromatin modifiers, with transcriptional silenc-
ing as the net outcome. In response to differentiation cues,
KAP1 becomes phosphorylated by MSK1 on Ser473, G9a
and HDAC1 are released, and the transcriptional activa-
tion potential of the MyoD/Mef2D complex is unleashed,
resulting in the expression of muscle genes (Fig. 7F).
KAP1 itself is not known to bind DNA directly but is
recruited to genomic loci, notably through its RBCC-
mediated interaction with KRAB-ZFPs that bind specific
DNA sequences. Transcriptional silencing ensues at
KRAB-ZFP-bound loci via the recruitment of SETDB1,
NuRD-associated HDACs, and HP1 (Friedman et al.
1996). Here, we demonstrate that, in muscle cells, the
RBCC domain also mediates the docking of KAP1 at
MyoD/Mef2D-enriched cis-regulatory regions, but, in
this case, the scaffold protein brings in a distinct set of
chromatin modifiers, including G9a, HDAC1, LSD1, and
p300. The bases for this difference are unknown. KRAB-
ZFPs recruit KAP1 as a trimer (Peng et al. 2000). Whether
similar high-order KAP1 complexes are formed at MyoD/
Mef2D-bearing loci remains to be determined, but it
would certainly allow for the assembly of a large platform
spanning multiple transcription modulators at CRMs,
consistent with our observations that an extensive group
Figure 6. KAP1 phosphorylation disrupts its
association with corepressor complexes. (A)
KAP1 and its associated proteins were immuno-
precipitated from NEs prepared from proliferat-
ing C2 myoblasts and analyzed by Western blot.
(B) G9a and its associated protein were identified
in proliferating myoblasts as outlined in A. (C)
Flag-KAP1(WT) was expressed in proliferating C2
myoblasts and subjected to treatment with 5 mM
PF3644022 for 16 h before harvesting the cells.
Flag-KAP1 was immunoprecipitated from cell
extracts using an anti-Flag antibody and analyzed
by Western blot using the indicated antibodies.
(D) KAP1 and its associated proteins were im-
munoprecipitated from NEs prepared from dif-
ferentiating C2 myotubes (48 h) and analyzed by
Western blot. (E) LSD1 was immunoprecipitated
from differentiating myotubes and examined for
its ability to associate with KAP1 byWestern blot.
(F) Immunoprecipitation of p300 was performed in
differentiating C2 myoblasts, and the interaction
with KAP1 was determined by Western blot using
antibodies as indicated. (G) C2 myoblasts express-
ing either the phosphomimic protein Flag-
S
473
DKAP1 or the nonphosphorylatable mutant
Flag-S
473
AKAP1 were induced to differentiate for
48 h. KAP1 proteins were immunopurified from
NEs using an anti-Flag antibody, and the result-
ing eluates were analyzed by Western blot using
the indicated antibodies. (H) C2 myoblasts
expressing either the wild-type KAP1 or the
nonphosphorylatable S
473
AKAP1 mutant were
induced to differentiate for 48 h. Chromatin
was immunoprecipitated using antibodies recog-
nizing HDAC1 (top) and G9a/GLP (bottom) and
quantitated by qPCR using primer sets specific
for the indicated genomic regions. Values are
represented as the mean 6 SEM as a percentage
of the input chromatin. n = 3; (**) P < 0.01; (n.s.)
not significant.
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of corepressors and coactivators is associated with KAP1
at muscle genes. The specific domains and residues of
KAP1 that are engaged in recruiting the various sets of
chromatinmodifiers identified in this and previous studies
also need to be defined. Nevertheless, it is noteworthy that
phosphorylation of KAP1 at Ser824 blocks its ability to
recruit SETDB1 (Ivanov et al. 2007; Iyengar and Farnham
2011), whereas its phosphorylation at Ser473 was pre-
viously reported instead to impair its interaction with
HP1 (Chang et al. 2008). Here, we demonstrate that
targeting of Ser473 by MSK1 kinase releases G9a and
HDAC1 from KAP1/MyoD/Mef2D complexes, confirm-
ing that motifs different from those involved in recruiting
SETDB1 are engaged in binding these repressors.
A constitutively active recombinant MSK1 derivative
could phosphorylate KAP1 in vitro, yet inhibitors of both
this kinase and p38 MAPK could block this process in
tissue culture. Consistent with previous findings that p38
MAPK phosphorylates MSK1 to activate its kinase activ-
ity (Pierrat et al. 1998), our results suggest that MSK1-
mediated phosphorylation of KAP1 takes place upon the
well-characterized activation of p38MAPK signaling that
occurs during differentiation (Zetser et al. 1999). Of note,
MSK1-mediated KAP1 phosphorylation most likely hap-
pens only at specific gene promoters, ensuring that the
repressive activity of KAP1 is not globally inactivated.
This scenario is corroborated by the finding that MSK1 is
targeted to at least a subset of muscle genes during
muscle differentiation (Fig. 4A; Stojic et al. 2011) and is
reminiscent of the ATM-mediated phosphorylation of
KAP1 on Ser824 specifically at sites of DNA damage
(White et al. 2006, 2012).
Figure 7. KAP1 phosphorylation induces a change
in coregulatory molecules at muscle genes. (A) Cell
extracts prepared from C2 myoblasts expressing
either control (shCtrl) or shRNAs against KAP1
(shKAP1#1 or shKAP1#2) were subjected to immu-
noprecipitation using anti-methyl (K
267) Mef2D an-
tibody. Immunopurified proteins were analyzed by
Western blot using the indicated antibodies. (B) C2
myoblasts were incubated with either 5 mM
PF3644022 or DMSO vehicle for 16 h, and cell
extracts were analyzed by Western blot using
KAP1 or S
473pKAP1 antibodies. (C) Gene expression
was examined in C2 myoblasts after incubation
with 5 mM PF3644022 (or DMSO vehicle) for 16 h.
RT-qPCR was performed using primers for specific
genes as indicated. Values are expressed as themean6
SEM relative to the internal control GAPDH, where
the expression was normalized to 1. (*) P < 0.05; (**)
P < 0.01. (D) ChIP assays were performed for KAP1,
HDAC1, H3Ac, p300, LSD1, Mef2D, or MyoD using
chromatin prepared from C2 myoblasts that had
been treated with 5 mM PF3644022 (or DMSO
vehicle) for 16 h. Immunopurified DNA was quan-
tified by qPCR using probes that recognize the
indicated genomic regions and are represented as
the mean 6 SEM as a percentage of the input
chromatin. (**) P < 0.01; (n.s.) not significant. (E)
Chromatin was prepared from differentiating C2
myotubes (48 h) that expressed shKAP1 or shCtrl.
Chromatin was then immunoprecipitated using
antibodies recognizing p300 or H3K27ac and quan-
titated by qPCR using primer sets specific for the
indicated genomic regions. Values are represented as
mean 6 SEM and were calculated as the percentage
of input chromatin (p300) or relative enrichment
over the ZFP180 39 untranslated region (UTR)
(H3K27ac). (*) P < 0.05; (**) P < 0.01. (See also
Supplemental Fig. S6B,C.) (F) Model for the bimodal
role of KAP1 in regulating MyoD transcriptional
activity at muscle genes. In proliferating myoblasts,
MyoD and Mef2D cooperate to allow efficient recruitment of KAP1. Promoter-tethered KAP1 then serves as a platform for the
assembly of coregulatory complexes that include both corepressors (G9a and HDAC1) and coactivators (LSD1 and p300). The assembly
of this complex results in the hypermethylation of Mef2D and hypoacetylation of histones, which establishes a transcriptionally poised
state at the promoter. Upon differentiation, up-regulation of p38 MAPK signaling leads to activation of the downstream kinase MSK1
that phosphorylates KAP1 at S473. Phosphorylation of KAP1 at S473 results in the dissociation of corepressors (HDAC1 and G9a) but
not coactivators (p300 and LSD1), leading to the formation of an open chromatin state that is permissive to high-level expression of
muscle genes.
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Our results indicate that KAP1 is essential to the
efficient assembly of corepressor and coactivator com-
plexes at muscle gene promoters. However, we note that
previous studies have identified direct interactions be-
tween MyoD and G9a (Ling et al. 2012) or between
MyoD and p300 (Sartorelli et al. 1997). Taken together,
these results suggest that the MyoD/Mef2/KAP1 com-
plex bound at muscle CRMs likely mediates multiple
independent interactions with a set of coregulatory
molecules, likely to maximize the specificity and effi-
ciency of this recruitment at highly selected genomic
loci. In this context, it is interesting to note that the
corepressor G9a has previously been demonstrated to
reduce the transcriptional activity of both MyoD (Ling
et al. 2012) and Mef2D (Choi et al. 2014) through
methylation of specific lysine residues within these
transcription factors. Conversely, corresponding lysine
residues are acetylated upon differentiation where
MyoD and Mef2D serve as transcriptional activators. In
the case ofMef2D, the conversion from the methylated to
the acetylated state is facilitated by LSD1-mediated
demethylation of K
267meMef2D, promoting transcrip-
tional activation of muscle genes (Choi et al. 2014). Our
data suggest a regulatory mechanism by which G9a
mediates methylation of Mef2D and MyoD to reinforce
the transcriptionally repressive state at muscle genes in
proliferating myoblasts. Upon differentiation, displace-
ment of G9a following KAP1 phosphorylation allows
LSD1-mediated demethylation of MyoD and Mef2D,
which in turn ensures the assembly of the full comple-
ment of transcription coactivators required for high-level
gene expression. Thus, we propose that the use of KAP1-
associated coregulatory molecules to modify the tran-
scriptional outcome of MyoD and Mef2D at muscle
CRMs represents a self-reinforcing loop that helps ensure
that transcription is repressed in proliferating myoblasts
but can be rapidly activated in response to differentiation
cues.
In conclusion, our results identify the KAP1/MyoD/
Mef2D axis as a dynamic transcriptional regulatory
system in which corepressor and coactivator complexes
are superimposed in a combinatorial and signal-depen-
dent fashion to modulate the efficient initiation of the
muscle gene expression program. It remains to be
determined whether the bivalent nature of KAP1
as a key regulator of the activity of transcription
factor-bound CRMs is specific to MyoD/Mef2D and
myogenesis or is used by additional combinations of
proteins engaged in controlling cell fate determination
in other lineages.
Materials and methods
Myoblast cultures
Mouse C2C12myoblasts (Yaffe and Saxel 1977) were maintained
in DMEM supplemented with 10% FCS. For differentiation
studies, near confluent cells were switched to low-serumDMEM
medium (1% [v/v] horse serum, 10 mg mL1 insulin, 10 mg mL1
transferrin). For analysis of kinase activity in C2C12 cells, either
proliferating or differentiating cells were treated with the kinase
inhibitor SB203580 (10mM), PF3644022 (5mM) Ly294002 (20mM),
orH89 (10mM) for 2 h prior to harvesting (unless otherwise noted).
For knockdown and complementation studies, proliferating
C2C12 cells were transduced at a multiplicity of infection (MOI)
of 20 with lentiviral particles targeting KAP1, MyoD, MSK1, or
a control (Luciferase). At 48 h after transduction, infected cells
were selected in growth medium containing 2 mg mL1 puro-
mycin for an additional 72 h. Infected cells were maintained to
near confluency and allowed to differentiate for 48 h.
Isogenic cell lines expressing C-terminal Flag-tagged cDNA
for MyoD, KAP1(WT), S
473
AKAP1, and S
473
DKAP1 were gener-
ated as described earlier (Sebastian et al. 2013). Briefly, the
mouse cDNAs encoding MyoD-Flag and KAP1(WT)-Flag were
cloned into the multiple cloning site of a pCDNA5/FRT/TO
plasmid. The plasmid pCDNA5/FRT/TO-S
473
AKAP1-Flag and
pCDNA5/FRT/TO-S
473
DKAP1-Flag mutants were generated
with QuickChange site-directed mutagenesis kit (Stratagene).
Individual plasmids were transfected into C2iFRT cells
(Sebastian et al. 2013) and selected for hygromycin B resistance
as outlined in the Flp-In system protocol. These cell lines were
termed C2iFRT-MyoD, C2iFRT-KAP1(WT), C2iFRT-S
473
AKAP1,
and C2iFRT-S
473
DKAP1.
RNA-seq
Total RNA was isolated from proliferating or differentiating
C2C12 cells using the RNeasy minikit (Qiagen) under standard
conditions. Library preparation and 100-base-pair (bp) single-end
RNA-seq were performed using standard Illumina procedures for
the HiSeq 2000 platform. The reads were mapped to the mm9
genome using TopHat’s sensitive mode (Kim et al. 2013), not
allowing for multiple hits, the discovery of novel junctions, or
indels. After mapping, we normalized the counts and performed
a likelihood ratio test as implemented in the Bioconductor
package DEseq2. We tested the null hypothesis that log2 fold
changes for multiple batches were equal to zero. Genes with
a fold change bigger than two and a fold change <0.5 were
considered to be differentially expressed.
ChIP and ChIP-seq
Histone modifications were analyzed using native ChIP as pre-
viously described (Brand et al. 2008). For cross-linked ChIP assay,
chromatin was prepared from 107 C2C12 cells (proliferating or
differentiating) as previously described (Rowe et al. 2013b).
Fragmented chromatin was immunoprecipitated using the spec-
ified antibodies or control IgG. Immunoprecipitated DNA was
quantified by Qubit (Life Technologies) and subjected to qPCR or
high-throughput sequencing analysis. For ChIP-seq experiments,
libraries for sequencing were prepared from total input chroma-
tin and immunoprecipitated DNA as previously described
(Santoni de Sio et al. 2012) using ;10 ng of chromatin. Libraries
were subjected to 100-bp single-end read analysis on an Illumina
GenomeAnalyzer IIx. Reads weremapped to themurine genome
assembly mm9 using Bowtie (Langmead and Salzberg 2012),
allowing a maximum of three mismatches. In cases of multiple
alignments, the one with best mapping quality was reported. In
cases of multiple alignments with the samemapping quality, one
of them was reported at random. The peaks were called using
either the MACS program (Zhang et al. 2008) or the SICER
algorithm for histone modification marks (Zang et al. 2009) and
were normalized to the total input chromatin signal using the
default software parameters. ChIP-seq data were aligned with
available data in proliferating myoblasts and differentiating
myotubes for MyoD (http://www.genome.ucsc.edu/ENCODE,
generated by the Wold group at California Institute of Technol-
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ogy); H3K27ac, H3K4me3, and H3K4me1 (generated by the Brian
Dynlacht group); and published Mef2Da2 data sets (Sebastian
et al. 2013). To assign co-occupancy, we ran the .BED files with
the peaks coordinates generated by MACS or SICER using the
intersectBed function of Bedtools software version 2.22.0
(Quinlan and Hall 2010). We asked for an overlap of at least
one base to consider two peaks as overlapping. All ChIP-seq data
reported in this study have been deposited in the Gene Expres-
sion Omnibus (GEO) database (GSE62664).
Statistical analyses
The statistical significance of the differences between relative
expression was assessed with two-way ANOVA. The statistical
significance of the differences between percentage values was
assessed with a Kruskal-Wallis ranks test.
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